Index S&P 500
P/E 32.21
EPS (ttm) 3.47
Insider Own 0.28%
Shs Outstand 244.00M
Perf Week 1.06%
Market Cap 27.02B
Forward P/E 13.21
EPS next Y 8.45
Insider Trans -22.70%
Shs Float 241.30M
Perf Month -0.07%
Income 851.00M
PEG 2.48
EPS next Q 1.62
Inst Own 89.93%
Short Float 3.46%
Perf Quarter 16.33%
Sales 226.99B
P/S 0.12
EPS this Y 1.39%
Inst Trans -1.37%
Short Ratio 4.34
Perf Half Y 2.03%
Book/sh -13.17
P/B -
EPS next Y 10.73%
ROA 1.92%
Short Interest 8.35M
Perf Year 24.35%
Cash/sh 21.21
P/C 5.26
EPS next 5Y 13.00%
ROE -
52W Range 89.00 - 116.05
Perf YTD 10.80%
Dividend Est. 2.04 (1.83%)
P/FCF 8.31
EPS past 5Y -5.30%
ROI 46.12%
52W High -3.76%
Beta 0.61
Dividend TTM 2.01 (1.80%)
Quick Ratio 0.56
Sales past 5Y 9.33%
Gross Margin 3.16%
52W Low 25.49%
ATR (14) 1.70
Dividend Ex-Date Oct 01, 2024
Current Ratio 0.98
EPS Y/Y TTM 247.35%
Oper. Margin 0.94%
RSI (14) 56.54
Volatility 1.02% 1.53%
Employees 48900
Debt/Eq -
Sales Y/Y TTM 10.72%
Profit Margin 0.37%
Recom 2.47
Target Price 118.73
Option/Short Yes / Yes
LT Debt/Eq -
EPS Q/Q 480.95%
Payout 58.20%
Rel Volume 0.33
Prev Close 111.98
Sales Surprise 2.09%
EPS Surprise 6.12%
Sales Q/Q 12.00%
Earnings Nov 01 BMO
Avg Volume 1.92M
Price 111.69
SMA20 0.26%
SMA50 3.21%
SMA200 6.67%
Trades
Volume 450,415
Change -0.26%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-26-24 Initiated
Leerink Partners
Outperform
$125
Feb-09-24 Upgrade
Argus
Hold → Buy
Jan-03-24 Initiated
Barclays
Overweight
$117
Dec-14-23 Initiated
Wells Fargo
Underweight
$96
Jul-10-23 Downgrade
Evercore ISI
Outperform → In-line
$100
Mar-31-23 Initiated
Citigroup
Neutral
$77
Feb-03-23 Upgrade
Robert W. Baird
Neutral → Outperform
$87 → $94
Nov-04-22 Upgrade
BofA Securities
Underperform → Neutral
$64 → $80
Aug-22-22 Resumed
Morgan Stanley
Overweight
$70 → $76
May-26-22 Downgrade
Barclays
Overweight → Equal Weight
May-18-22 Upgrade
Evercore ISI
In-line → Outperform
$55 → $68
Apr-12-22 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$74
Apr-01-22 Resumed
Credit Suisse
Neutral
$58
Aug-06-21 Downgrade
Deutsche Bank
Buy → Hold
$62 → $51
Aug-05-21 Downgrade
BofA Securities
Buy → Underperform
$69 → $56
May-10-21 Downgrade
Robert W. Baird
Outperform → Neutral
$66 → $64
Jan-08-21 Upgrade
Wolfe Research
Underperform → Peer Perform
Nov-02-20 Upgrade
Barclays
Equal Weight → Overweight
$57
Sep-25-20 Upgrade
Deutsche Bank
Hold → Buy
$61
Jul-20-20 Upgrade
Guggenheim
Neutral → Buy
Show Previous Ratings
Today 09:05AM
Oct-01-24 06:15PM
09:40AM
Sep-27-24 07:00AM
(The Wall Street Journal)
Sep-25-24 06:15PM
06:45AM
Loading…
Sep-24-24 06:45AM
Sep-23-24 09:40AM
Sep-20-24 09:30AM
09:15AM
Sep-19-24 06:00PM
Sep-17-24 09:50AM
07:00AM
Sep-16-24 06:15PM
Sep-10-24 07:30AM
Sep-09-24 06:00PM
05:34PM
Loading…
Aug-28-24 05:34PM
03:16PM
(Investor's Business Daily)
11:00AM
Aug-26-24 02:31PM
Aug-23-24 09:27PM
Aug-22-24 11:00AM
10:00AM
Aug-21-24 04:23PM
07:30AM
Aug-16-24 01:01AM
Aug-15-24 05:45PM
03:05AM
(Thomson Reuters StreetEvents)
Aug-14-24 07:22PM
04:20PM
(Investor's Business Daily)
04:06PM
(Investor's Business Daily)
03:15PM
Loading…
03:15PM
(Investor's Business Daily)
01:46PM
(Investor's Business Daily)
12:29PM
(Investor's Business Daily)
12:29PM
12:29PM
12:02PM
11:42AM
11:23AM
11:00AM
(Investor's Business Daily)
10:59AM
09:53AM
09:30AM
08:02AM
(Investor's Business Daily)
08:01AM
07:40AM
06:47AM
(Associated Press Finance)
06:30AM
Aug-13-24 09:40AM
09:01AM
07:32AM
Aug-12-24 10:52AM
08:43AM
Aug-09-24 09:15AM
09:08AM
Aug-08-24 04:23PM
(Investor's Business Daily)
Aug-07-24 10:00AM
Aug-06-24 06:00PM
Jul-31-24 06:00PM
Jul-26-24 09:40AM
Jul-24-24 06:00PM
Jul-23-24 06:15PM
11:27AM
06:45AM
Jul-22-24 06:00AM
Jul-17-24 06:00PM
Jul-15-24 06:15PM
Jul-12-24 12:08PM
Jul-11-24 07:00AM
Jul-09-24 06:15PM
Jul-04-24 12:15PM
Jun-28-24 08:10PM
Jun-27-24 03:15PM
(Investor's Business Daily)
Jun-26-24 06:15PM
Jun-24-24 06:47AM
Jun-18-24 07:59PM
Jun-11-24 01:03PM
Jun-10-24 06:56AM
Jun-09-24 09:00AM
Jun-06-24 02:58PM
02:25PM
Jun-02-24 04:00PM
May-29-24 09:40AM
May-28-24 09:55AM
May-22-24 05:17PM
May-19-24 08:09AM
May-17-24 09:00AM
07:44AM
May-15-24 07:36AM
May-13-24 09:40AM
May-08-24 08:06PM
May-07-24 04:15PM
06:40AM
May-06-24 02:21PM
02:00PM
09:00AM
May-03-24 01:12PM
11:41AM
09:31AM
03:10AM
01:11AM
Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. The firm operates through the Pharmaceutical and Medical segments. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products. The Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical, and laboratory products. The company was founded by Robert D. Walter in 1979 and is headquartered in Dublin, OH.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Mayer Jessica L Chief Legal/Compliance Officer Aug 21 '24 Sale 109.39 16,573 1,812,920 75,971 Aug 22 08:43 AM Mayer Jessica L Officer Aug 21 '24 Proposed Sale 109.39 16,573 1,812,898 Aug 21 04:25 PM Mayer Jessica L Chief Legal/Compliance Officer Aug 15 '24 Option Exercise 72.76 8,673 631,017 112,425 Aug 19 08:30 PM Mayer Jessica L Chief Legal/Compliance Officer Aug 15 '24 Sale 106.48 17,896 1,905,566 94,529 Aug 19 08:30 PM Alt Aaron E Chief Financial Officer Aug 19 '24 Sale 108.91 2,323 252,998 36,867 Aug 19 08:28 PM Greene Michelle D. Chief Information Officer Aug 19 '24 Sale 108.85 4,000 435,400 19,242 Aug 19 08:26 PM Hollar Jason M. Chief Executive Officer Aug 19 '24 Sale 109.02 46,455 5,064,524 197,636 Aug 19 08:24 PM Hollar Jason M. Chief Executive Officer Aug 16 '24 Sale 108.87 26,716 2,908,571 244,091 Aug 19 08:24 PM Snow Ola M Chief Human Resources Officer Aug 19 '24 Option Exercise 77.38 17,667 1,367,147 62,163 Aug 19 08:23 PM Snow Ola M Chief Human Resources Officer Aug 19 '24 Sale 109.00 34,647 3,776,523 27,516 Aug 19 08:23 PM Snow Ola M Chief Human Resources Officer Aug 16 '24 Sale 108.00 3,294 355,752 45,439 Aug 19 08:23 PM Mason Stephen M CEO, GMPD Segment Aug 19 '24 Option Exercise 83.62 14,961 1,251,075 87,669 Aug 19 08:21 PM Mason Stephen M CEO, GMPD Segment Aug 19 '24 Sale 109.21 46,998 5,132,848 40,671 Aug 19 08:21 PM Mason Stephen M Officer Aug 19 '24 Proposed Sale 109.22 46,998 5,132,896 Aug 19 05:41 PM Alt Aaron E Officer Aug 19 '24 Proposed Sale 108.91 2,323 252,992 Aug 19 05:05 PM Greene Michelle D. Officer Aug 19 '24 Proposed Sale 108.85 4,000 435,389 Aug 19 05:05 PM Hollar Jason M. Officer Aug 19 '24 Proposed Sale 109.02 46,455 5,064,517 Aug 19 05:03 PM Snow Ola M Officer Aug 19 '24 Proposed Sale 108.99 34,647 3,776,225 Aug 19 04:55 PM Snow Ola M Officer Aug 16 '24 Proposed Sale 107.99 3,294 355,733 Aug 16 04:15 PM Hollar Jason M. Officer Aug 16 '24 Proposed Sale 108.87 26,716 2,908,665 Aug 16 04:08 PM Mayer Jessica L Officer Aug 15 '24 Proposed Sale 106.48 17,896 1,905,598 Aug 15 02:46 PM WEITZMAN DEBORAH CEO, Pharmaceutical Segment Nov 27 '23 Option Exercise 74.10 27,642 2,048,356 71,844 Nov 29 09:14 AM WEITZMAN DEBORAH CEO, Pharmaceutical Segment Nov 27 '23 Sale 106.31 36,642 3,895,411 35,202 Nov 29 09:14 AM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite